关注
Amulya K Panda
Amulya K Panda
Associate Director, Panacea Biotec Ltd and Former Director, National Inst of Immunology, New Delhi
在 panaceabiotec.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Solubilization and refolding of bacterial inclusion body proteins
SM Singh, AK Panda
Journal of bioscience and bioengineering 99 (4), 303-310, 2005
11562005
Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process
A Singh, V Upadhyay, AK Upadhyay, SM Singh, AK Panda
Microbial cell factories 14, 1-10, 2015
6132015
3-D Tumor Model for In Vitro Evaluation of Anticancer Drugs
JL Horning, SK Sahoo, S Vijayaraghavalu, S Dimitrijevic, JK Vasir, ...
Molecular pharmaceutics 5 (5), 849-862, 2008
3982008
Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli
AK Patra, R Mukhopadhyay, R Mukhija, A Krishnan, LC Garg, AK Panda
Protein expression and purification 18 (2), 182-192, 2000
3422000
Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response
V Kanchan, AK Panda
Biomaterials 28 (35), 5344-5357, 2007
3062007
Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen
HK Dhiman, AR Ray, AK Panda
Biomaterials 26 (9), 979-986, 2005
2882005
Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells
SK Sahoo, AK Panda, V Labhasetwar
Biomacromolecules 6 (2), 1132-1139, 2005
2322005
Eudragit S100 entrapped insulin microspheres for oral delivery
D Jain, AK Panda, DK Majumdar
Aaps Pharmscitech 6, E100-E107, 2005
2302005
Development of enteric submicron particle formulation of papain for oral delivery
M Sharma, V Sharma, AK Panda, DK Majumdar
International journal of nanomedicine, 2097-2111, 2011
216*2011
Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants
RS Raghuvanshi, YK Katare, K Lalwani, MM Ali, O Singh, AK Panda
International journal of pharmaceutics 245 (1-2), 109-121, 2002
1792002
Bioprocessing of Therapeutic Proteins from the Inclusion Bodies of Escherichia coli
AK Panda
Biotechnology in India II, 43-93, 2003
1722003
Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles
YK Katare, T Muthukumaran, AK Panda
International journal of pharmaceutics 301 (1-2), 149-160, 2005
1522005
Solubilization of recombinant ovine growth hormone with retention of native‐like secondary structure and its refolding from the inclusion bodies of Escherichia coli
RH Khan, KBCA Rao, ANS Eshwari, SM Totey, AK Panda
Biotechnology progress 14 (5), 722-728, 1998
1521998
Plant cell reactors—a perspective
AK Panda, S Mishra, VS Bisaria, SS Bhojwani
Enzyme and microbial technology 11 (7), 386-397, 1989
1431989
Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli
AK Upadhyay, A Murmu, A Singh, AK Panda
PloS one 7 (3), e33951, 2012
1372012
Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines
HK Dhiman, AR Ray, AK Panda
Biomaterials 25 (21), 5147-5154, 2004
1352004
Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria
C Dende, J Meena, P Nagarajan, VA Nagaraj, AK Panda, G Padmanaban
Scientific reports 7 (1), 10062, 2017
1252017
Bacterial inclusion bodies: a treasure trove of bioactive proteins
P Singhvi, A Saneja, S Srichandan, AK Panda
Trends in Biotechnology 38 (5), 474-486, 2020
1132020
Solubilization and refolding of inclusion body proteins
A Singh, V Upadhyay, AK Panda
Insoluble proteins: methods and protocols, 283-291, 2015
1062015
Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein
AK Upadhyay, A Singh, KJ Mukherjee, AK Panda
Frontiers in microbiology 5, 486, 2014
1032014
系统目前无法执行此操作,请稍后再试。
文章 1–20